Market Overview:
The global inflammatory marker market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The market growth is attributed to the increasing prevalence of chronic diseases, rising demand for early diagnosis and treatment, and technological advancements in the field of biomarker research and development. Based on type, the global inflammatory marker market is segmented into interlukin, C reactive protein (CRP), cellular adhesion molecule (CAM), tumor necrosis factor-α (TNF-α), and others. The CRP segment accounted for the largest share of the global inflammatory marker market in 2017 owing to its high sensitivity and specificity for detecting inflammation. Based on application, the global inflammatory marker market is divided into hospitals, diagnostic laboratories, research laboratories, and others. The hospitals segment accounted for the largest share of the global inflammatory marker market in 2017 due to increasing demand for early diagnosis and treatment of chronic diseases.
Product Definition:
An inflammatory marker is a substance that is released into the bloodstream in response to inflammation. Inflammatory markers can be used to diagnose and monitor inflammation, and they may also be used to predict the risk of developing certain diseases.
Interlukin:
Interlukin is a growth factor that enhances the proliferation of cells and blocks their differentiation. It's main function is to act as an intercellular messenger between the two types of cells in our bodies, namely immune system cells and fibroblasts (connective tissue). Interlukin also has some other functions such as it helps repair tissues by enhancing angiogenesis (the formation of new blood vessels), wound healing, and cartilage & bone reconstruction.
C Reactive Protein:
C-reactive protein (CRP) is an amino acid derived from the body and found in high levels in the blood of patients with chronic inflammation. CRP is mainly used as a diagnostic tool for inflammatory diseases, such as rheumatoid arthritis, osteoporosis, cardiovascular disease and cancer. It also plays a key role in wound healing process.
Application Insights:
The research laboratories segment dominated the market in 2017. This is attributed to factors such as increasing government funding for medical research and rising incidences of chronic diseases that require accurate diagnostic measures. For instance, according to the CDC, around 300 million adults in U.S., have diabetes or prediabetes which requires regular monitoring to maintain optimum health. Therefore, a large patient base across the globe is expected to generate significant demand for inflammatory markers during the forecast period.
The hospital segment is anticipated to witness lucrative growth over the forecast period owing to factors such as growing awareness about early diagnosis and increased spending on healthcare worldwide including private and public funding agencies like WHO & governments of various countries etc.
Regional Analysis:
North America dominated the global market in 2017. The presence of key players, advanced healthcare infrastructure, and high adoption rate for technologically advanced products are some of the major factors responsible for its large share. In addition, increasing prevalence of chronic diseases such as cardiovascular diseases (CVDs), diabetes, cancer is also expected to drive regional growth over the forecast period.
Asia Pacific is expected to grow at a lucrative rate during the forecast period owing to rising healthcare expenditure and growing patient awareness levels regarding early diagnosis of chronic conditions among others’ causes & treatment options.
Major companies operating in this space include but are not limited to; Abbott Laboratories; AbbVie Inc.; Amgen Inc.; AstraZeneca; Biogen Inc.
Growth Factors:
- Increasing prevalence of chronic diseases: The global prevalence of chronic diseases is increasing at an alarming rate. This is primarily because of the changing lifestyle and dietary habits of people across the world. The increase in the number of people suffering from chronic diseases will lead to an increase in demand for inflammatory marker tests, thereby driving growth for the inflammatory marker market.
- Technological advancements: There has been a significant advancement in technology over the past few years, which has led to the development of novel and more accurate methods for detecting inflammation markers. This is likely to drive growth for the inflammatory marker market in coming years as healthcare providers adopt these new technologies to improve diagnosis and treatment outcomes for their patients.
- Growing awareness about biomarkers: There is growing awareness among healthcare professionals and consumers about biomarkers and their role in diagnosing various health conditions early on, which is likely to drive demand for inflammatory marker tests in coming years. This will help boost growth prospects for the inflammatory marker market globally.
Scope Of The Report
Report Attributes
Report Details
Report Title
Inflammatory Marker Market Research Report
By Type
Interlukin, C Reactive Protein, Cellular Adhesion Molecule, Tumor Necrosis Factor-α, Others
By Application
Hospitals, Diagnostic Laboratories, Research Laboratories, Others
By Companies
Merck, Novartis, Thermo Fisher Scientific, Cell Signaling Technology, Boditech Med, PHC Holdings, Abbott, Siemens, BG Medicine
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
134
Number of Tables & Figures
94
Customization Available
Yes, the report can be customized as per your need.
Global Inflammatory Marker Market Report Segments:
The global Inflammatory Marker market is segmented on the basis of:
Types
Interlukin, C Reactive Protein, Cellular Adhesion Molecule, Tumor Necrosis Factor-α, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Diagnostic Laboratories, Research Laboratories, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Merck
- Novartis
- Thermo Fisher Scientific
- Cell Signaling Technology
- Boditech Med
- PHC Holdings
- Abbott
- Siemens
- BG Medicine
Highlights of The Inflammatory Marker Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Interlukin
- C Reactive Protein
- Cellular Adhesion Molecule
- Tumor Necrosis Factor-α
- Others
- By Application:
- Hospitals
- Diagnostic Laboratories
- Research Laboratories
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Inflammatory Marker Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Inflammatory marker is a blood test that measures the level of inflammation in your body. Inflammation can be caused by a variety of factors, including infection, injury, and autoimmune disease. High levels of inflammation can lead to pain and swelling, which may cause serious health problems.
Some of the major companies in the inflammatory marker market are Merck, Novartis, Thermo Fisher Scientific, Cell Signaling Technology, Boditech Med, PHC Holdings, Abbott, Siemens, BG Medicine.
The inflammatory marker market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Inflammatory Marker Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Inflammatory Marker Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Inflammatory Marker Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Inflammatory Marker Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Inflammatory Marker Market Size & Forecast, 2018-2028
4.5.1 Inflammatory Marker Market Size and Y-o-Y Growth
4.5.2 Inflammatory Marker Market Absolute $ Opportunity
Chapter 5 Global Inflammatory Marker Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Inflammatory Marker Market Size Forecast by Type
5.2.1 Interlukin
5.2.2 C Reactive Protein
5.2.3 Cellular Adhesion Molecule
5.2.4 Tumor Necrosis Factor-α
5.2.5 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Inflammatory Marker Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Inflammatory Marker Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Diagnostic Laboratories
6.2.3 Research Laboratories
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Inflammatory Marker Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Inflammatory Marker Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Inflammatory Marker Analysis and Forecast
9.1 Introduction
9.2 North America Inflammatory Marker Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Inflammatory Marker Market Size Forecast by Type
9.6.1 Interlukin
9.6.2 C Reactive Protein
9.6.3 Cellular Adhesion Molecule
9.6.4 Tumor Necrosis Factor-α
9.6.5 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Inflammatory Marker Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Diagnostic Laboratories
9.10.3 Research Laboratories
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Inflammatory Marker Analysis and Forecast
10.1 Introduction
10.2 Europe Inflammatory Marker Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Inflammatory Marker Market Size Forecast by Type
10.6.1 Interlukin
10.6.2 C Reactive Protein
10.6.3 Cellular Adhesion Molecule
10.6.4 Tumor Necrosis Factor-α
10.6.5 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Inflammatory Marker Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Diagnostic Laboratories
10.10.3 Research Laboratories
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Inflammatory Marker Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Inflammatory Marker Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Inflammatory Marker Market Size Forecast by Type
11.6.1 Interlukin
11.6.2 C Reactive Protein
11.6.3 Cellular Adhesion Molecule
11.6.4 Tumor Necrosis Factor-α
11.6.5 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Inflammatory Marker Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Diagnostic Laboratories
11.10.3 Research Laboratories
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Inflammatory Marker Analysis and Forecast
12.1 Introduction
12.2 Latin America Inflammatory Marker Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Inflammatory Marker Market Size Forecast by Type
12.6.1 Interlukin
12.6.2 C Reactive Protein
12.6.3 Cellular Adhesion Molecule
12.6.4 Tumor Necrosis Factor-α
12.6.5 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Inflammatory Marker Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Diagnostic Laboratories
12.10.3 Research Laboratories
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Inflammatory Marker Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Inflammatory Marker Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Inflammatory Marker Market Size Forecast by Type
13.6.1 Interlukin
13.6.2 C Reactive Protein
13.6.3 Cellular Adhesion Molecule
13.6.4 Tumor Necrosis Factor-α
13.6.5 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Inflammatory Marker Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Diagnostic Laboratories
13.10.3 Research Laboratories
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Inflammatory Marker Market: Competitive Dashboard
14.2 Global Inflammatory Marker Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Merck
14.3.2 Novartis
14.3.3 Thermo Fisher Scientific
14.3.4 Cell Signaling Technology
14.3.5 Boditech Med
14.3.6 PHC Holdings
14.3.7 Abbott
14.3.8 Siemens
14.3.9 BG Medicine
